Logo image of XMTR

XOMETRY INC-A (XMTR) Stock Fundamental Analysis

USA - NASDAQ:XMTR - US98423F1093 - Common Stock

48.52 USD
-2 (-3.96%)
Last: 10/30/2025, 8:00:02 PM
48.01 USD
-0.51 (-1.05%)
Pre-Market: 10/31/2025, 4:00:49 AM
Fundamental Rating

4

Taking everything into account, XMTR scores 4 out of 10 in our fundamental rating. XMTR was compared to 50 industry peers in the Trading Companies & Distributors industry. The financial health of XMTR is average, but there are quite some concerns on its profitability. XMTR shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

XMTR had positive earnings in the past year.
In the past year XMTR had a positive cash flow from operations.
XMTR had negative earnings in each of the past 5 years.
In the past 5 years XMTR always reported negative operating cash flow.
XMTR Yearly Net Income VS EBIT VS OCF VS FCFXMTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

XMTR's Return On Assets of -8.97% is on the low side compared to the rest of the industry. XMTR is outperformed by 88.00% of its industry peers.
XMTR's Return On Equity of -22.78% is on the low side compared to the rest of the industry. XMTR is outperformed by 84.00% of its industry peers.
Industry RankSector Rank
ROA -8.97%
ROE -22.78%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
XMTR Yearly ROA, ROE, ROICXMTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 39.15%, XMTR is doing good in the industry, outperforming 72.00% of the companies in the same industry.
In the last couple of years the Gross Margin of XMTR has grown nicely.
The Profit Margin and Operating Margin are not available for XMTR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
XMTR Yearly Profit, Operating, Gross MarginsXMTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20

5

2. Health

2.1 Basic Checks

XMTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
XMTR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, XMTR has more shares outstanding
The debt/assets ratio for XMTR is higher compared to a year ago.
XMTR Yearly Shares OutstandingXMTR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XMTR Yearly Total Debt VS Total AssetsXMTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

XMTR has an Altman-Z score of 3.79. This indicates that XMTR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of XMTR (3.79) is better than 72.00% of its industry peers.
XMTR has a Debt/Equity ratio of 1.21. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of XMTR (1.21) is worse than 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 3.79
ROIC/WACCN/A
WACC8.98%
XMTR Yearly LT Debt VS Equity VS FCFXMTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

XMTR has a Current Ratio of 3.91. This indicates that XMTR is financially healthy and has no problem in meeting its short term obligations.
XMTR's Current ratio of 3.91 is amongst the best of the industry. XMTR outperforms 90.00% of its industry peers.
A Quick Ratio of 3.85 indicates that XMTR has no problem at all paying its short term obligations.
XMTR has a Quick ratio of 3.85. This is amongst the best in the industry. XMTR outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.85
XMTR Yearly Current Assets VS Current LiabilitesXMTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

XMTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 200.00%, which is quite impressive.
XMTR shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.19%.
The Revenue has been growing by 46.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1000%
Revenue 1Y (TTM)20.19%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%22.59%

3.2 Future

XMTR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 197.09% yearly.
Based on estimates for the next years, XMTR will show a quite strong growth in Revenue. The Revenue will grow by 18.30% on average per year.
EPS Next Y802.35%
EPS Next 2Y317.97%
EPS Next 3Y197.09%
EPS Next 5YN/A
Revenue Next Year21.08%
Revenue Next 2Y19.43%
Revenue Next 3Y18.54%
Revenue Next 5Y18.3%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
XMTR Yearly Revenue VS EstimatesXMTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
XMTR Yearly EPS VS EstimatesXMTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 255.37 indicates a quite expensive valuation of XMTR.
Compared to the rest of the industry, the Price/Earnings ratio of XMTR indicates a slightly more expensive valuation: XMTR is more expensive than 74.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of XMTR to the average of the S&P500 Index (26.19), we can say XMTR is valued expensively.
XMTR is valuated quite expensively with a Price/Forward Earnings ratio of 62.73.
Based on the Price/Forward Earnings ratio, XMTR is valued a bit more expensive than the industry average as 74.00% of the companies are valued more cheaply.
XMTR is valuated expensively when we compare the Price/Forward Earnings ratio to 22.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 255.37
Fwd PE 62.73
XMTR Price Earnings VS Forward Price EarningsXMTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XMTR Per share dataXMTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
XMTR's earnings are expected to grow with 197.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y317.97%
EPS Next 3Y197.09%

0

5. Dividend

5.1 Amount

No dividends for XMTR!.
Industry RankSector Rank
Dividend Yield N/A

XOMETRY INC-A

NASDAQ:XMTR (10/30/2025, 8:00:02 PM)

Premarket: 48.01 -0.51 (-1.05%)

48.52

-2 (-3.96%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners101.05%
Inst Owner Change0.05%
Ins Owners5.78%
Ins Owner Change-1.38%
Market Cap2.46B
Revenue(TTM)603.76M
Net Income(TTM)-61600000
Analysts81.25
Price Target47.69 (-1.71%)
Short Float %12.99%
Short Ratio7.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)319.09%
Min EPS beat(2)96.56%
Max EPS beat(2)541.62%
EPS beat(4)4
Avg EPS beat(4)230.87%
Min EPS beat(4)96.56%
Max EPS beat(4)541.62%
EPS beat(8)8
Avg EPS beat(8)136.96%
EPS beat(12)11
Avg EPS beat(12)97.33%
EPS beat(16)14
Avg EPS beat(16)77.75%
Revenue beat(2)1
Avg Revenue beat(2)0.86%
Min Revenue beat(2)-0.07%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)0.52%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)1.79%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.8%
Revenue beat(16)9
Avg Revenue beat(16)-0.15%
PT rev (1m)0%
PT rev (3m)33.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.27%
EPS NY rev (1m)0%
EPS NY rev (3m)20.38%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.89%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 255.37
Fwd PE 62.73
P/S 4.08
P/FCF N/A
P/OCF 1849.07
P/B 9.12
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.19
EY0.39%
EPS(NY)0.77
Fwd EY1.59%
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)0.03
OCFY0.05%
SpS11.89
BVpS5.32
TBVpS-0.47
PEG (NY)0.32
PEG (5Y)N/A
Graham Number4.77
Profitability
Industry RankSector Rank
ROA -8.97%
ROE -22.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.15%
FCFM N/A
ROA(3y)-9.09%
ROA(5y)-16.86%
ROE(3y)-18.95%
ROE(5y)-30.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.75%
GM growth 5Y16.61%
F-Score5
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 142.13%
Cap/Sales 3.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.85
Altman-Z 3.79
F-Score5
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)161.93%
Cap/Depr(5y)158.79%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1000%
EPS Next Y802.35%
EPS Next 2Y317.97%
EPS Next 3Y197.09%
EPS Next 5YN/A
Revenue 1Y (TTM)20.19%
Revenue growth 3Y35.7%
Revenue growth 5Y46.73%
Sales Q2Q%22.59%
Revenue Next Year21.08%
Revenue Next 2Y19.43%
Revenue Next 3Y18.54%
Revenue Next 5Y18.3%
EBIT growth 1Y19.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.04%
EBIT Next 3Y64.61%
EBIT Next 5Y46.68%
FCF growth 1Y69.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.61%
OCF growth 3YN/A
OCF growth 5YN/A

XOMETRY INC-A / XMTR FAQ

What is the fundamental rating for XMTR stock?

ChartMill assigns a fundamental rating of 4 / 10 to XMTR.


What is the valuation status for XMTR stock?

ChartMill assigns a valuation rating of 2 / 10 to XOMETRY INC-A (XMTR). This can be considered as Overvalued.


Can you provide the profitability details for XOMETRY INC-A?

XOMETRY INC-A (XMTR) has a profitability rating of 2 / 10.


Can you provide the PE and PB ratios for XMTR stock?

The Price/Earnings (PE) ratio for XOMETRY INC-A (XMTR) is 255.37 and the Price/Book (PB) ratio is 9.12.